Approval · Notice of Compliance 13617 · 2012
APPRILON: Notice of Compliance 13617
Issued August 31, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13617
- Date
- August 31, 2012
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Change in product name
- Therapeutic class
- Anti-Rosacea
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APPRILON | 02375885 | Marketed |
Medicinal ingredients
- DOXYCYCLINE MONOHYDRATE 40 MG per CAP